AFP and hepatocellular carcinoma: In multivariate analysis, multinodular HCC (HR = 2.144, p = 0.001), treatment-naïve patient (HR = 0.546, p = 0.004) and AFP > 100 ng/mL (HR = 2.437, p = 0.013) independently predicted RFS (internal validation by bootstrapping).